SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Elan Corporation, plc (ELN) -- Ignore unavailable to you. Want to Upgrade?

To: Robohogs who wrote (1584)2/8/2002 12:22:41 PM
From: Darrel McPherson  Respond to of 10345
 
Here's what I've done. I sold what I had in a margin account and kept what I had in my cash account. I was tempted to short Elan, but thought better not to...I should have earlier as a hedge. I think we are at a base where it could go higher, but if accounting problems do surface we could plummet much further until there is support. I can not risk that on margin.



To: Robohogs who wrote (1584)2/8/2002 8:09:53 PM
From: arnie h  Read Replies (1) | Respond to of 10345
 
<About the only bad news not priced in would be failure and/or delay in Antegren. Not saying that will happen but that is the one main reason I remain long along with the drug delivery technology.>

Elan is in the forefront of Alzheimer's d. R&D despite the problems with AN 1792. There is no one any deeper or broader.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News